PRKR has multiplied several times in around one year. It was trading below $1 and is now touching $4. The patent infringement lawsuit with Qualcomm is going okay and the recent ruling has been a boost to the stock sentiment. The court disagreed with Qualcomm’s Motion to drive out Parkervision's claims of indirect infringements which means that the things are definitely on track for Parkervision. It is reasonably sure that till the start of the trial in early October, the stock will remain stable, and may get stronger. Parkervision's near future depends very much on the progress of the trial and the news flow will determine how it will move. There is always a risk of negative outcome, and then the market will not take too kindly to that. However, after this ruling, the probability of that has reduced substantially. So investors who have been riding this wave can hold on. Caution is obviously recommended, and one should keep the trailing stop losses always ready. Parkervision is one great story in the IP monetizing business which has proved that smaller companies do have the potential to take on the biggies to enforce their patent rights. Several companies have now realized the potential of monetizing patents and companies have even changed their business model. Spherix IP (SPEX) recently sold its consultancy business to concentrate solely on building and IPR portfolio. Spherix is now a full service IP company and owns patents related to telecom sector. This is in addition to the main IPR portfolio building activity of drug research for diabetes and atherosclerosis. Spherix has been able to find the backing of investors like Hudson Bay Capital. ParkerVision is declaring its results on 9th May, and more than the figures, it will be the discussion on the lawsuit which will be awaited. Investors will hope for some news which can strengthen the uptrend.